BOSTON, Nov. 24, 2021 /PRNewswire/ -- Ginkgo
Bioworks (NYSE: DNA), the leading horizontal platform for cell
programming, announced today that management is scheduled to
participate in the following upcoming conferences:
- Piper Sandler Annual Healthcare Conference on
Tuesday, November 30, 2021
- Jefferies Alternative Protein & Related ESG
Summit on Wednesday, December 1,
2021 at 6:30 p.m. ET
- Goldman Sachs Byte-ology: The Convergence of
Biotechnology and Technology Conference on
Thursday, December 9, 2021 at
11:00 a.m. ET
Further details, webcast links, and replays of the presentations
where available will be posted on the company's investor relations
website at https://investors.ginkgobioworks.com/events.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program
cells as easily as we can program computers. The company's platform
is enabling biotechnology applications across diverse markets, from
food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo has also actively supported a number of COVID-19 response
efforts, including K-12 pooled testing, vaccine manufacturing
optimization, and therapeutics discovery. For more information,
visit www.ginkgobioworks.com.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-upcoming-conferences-301431387.html
SOURCE Ginkgo Bioworks